Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

If you or someone you care about might be at risk for RSV, consult your healthcare provider. — JT Editor's Note: This health service message is brought to you by GSK. It is produced by the ...

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both ...

Vaccines are available for the flu, COVID and RSV, and Russo and Omenka say vaccination could be crucial. "It is important for people to realize that these vaccines are critical for preventing ...

Even as GSK’s RSV vaccine launch hits a serious slowdown ... Miels explained. On Tuesday, Pfizer also reported $198 million in fourth-quarter sales for its RSV shot Abrysvo.

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both companies ...